罗马IV标准肠易激综合征患者为换取症状治愈而愿意接受药物治疗风险的意愿
该研究调查了752名罗马IV标准定义的肠易激综合征成人,采用标准博弈法评估其为了换取永久症状治愈而愿意接受的死亡风险中位数为2.0%(IQR 0.0%-9.0%),对应治愈机会为98.0%(IQR 91.0%-100.0%)。男性、持续腹痛、症状更重、抑郁评分异常、胃肠道症状特异性焦虑更高及IBS相关生活质量更低的患者愿意接受的死亡风险更高。结论认为患者愿意为治愈IBS症状而接受显著风险。
要点
- 752名罗马IV标准IBS患者为换取98.0%永久症状治愈机会,愿意接受死亡风险中位数为2.0%。
- 男性、持续腹痛、症状更重、抑郁异常、焦虑更高及生活质量更低者愿意接受的死亡风险更高。
- 愿意接受高于中位死亡风险者更多为男性、日常冒险倾向更高、有持续腹痛、抑郁更高及生活质量更低。
核心结论
- 患者愿意为治愈IBS症状而接受显著风险。
研究设计与样本
- 研究收集了752名罗马IV标准定义的肠易激综合征成人的 demographic、胃肠道症状、心理健康、生活质量及工作与日常活动影响数据。
- 采用标准博弈法,根据上述变量检查为换取症状治愈而愿意接受的死亡风险中位数。
主要发现
- 参与者愿意接受的死亡风险中位数为2.0%(IQR 0.0%-9.0%),以换取98.0%(IQR 91.0%-100.0%)的永久症状治愈机会。
- 男性愿意接受的死亡风险中位数高于女性(5.0% vs 2.0%,P < 0.001)。
- 有持续腹痛者愿意接受的死亡风险中位数高于无持续腹痛者(4.0% vs 1.0%,P < 0.001)。
- 症状更严重(趋势P = 0.005)、抑郁评分异常(趋势P < 0.001)、胃肠道症状特异性焦虑更高(趋势P < 0.001)及IBS相关生活质量更低(趋势P < 0.001)者愿意接受的死亡风险中位数更高。
- 愿意接受高于中位死亡风险者更可能为男性(17.1% vs 9.1%,P < 0.001)、日常生活中承担更高风险(趋势P = 0.008)、报告持续腹痛(53.1% vs 39.4%,P < 0.001),且抑郁评分更高(趋势P = 0.004)和生活质量更低(趋势P < 0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Some drugs for irritable bowel syndrome (IBS) have serious side effects. AIMS: To examine the willingness of individuals with IBS to accept risks with medication in return for symptom cure. METHODS: We collected demographic, gastrointestinal symptoms, psychological health, quality of life and impact on work and daily activities data from 752 adults with Rome IV-defined IBS. We examined median willingness to accept death in return for cure with a hypothetical medication using a standard gamble, according to these variables. RESULTS: Participants would accept a median 2.0% (IQR 0.0%-9.0%) risk of death in return for a 98.0% (IQR 91.0%-100.0%) chance of permanent symptom cure. The median accepted risk of death was higher in men (5.0% vs 2.0%, P < 0.001), those with continuous abdominal pain (4.0% vs 1.0%, P < 0.001), more severe symptoms (P = 0.005 for trend), abnormal depression scores (P < 0.001 for trend), higher gastrointestinal symptom-specific anxiety (P < 0.001 for trend), and lower IBS-related quality of life (P < 0.001 for trend). Those willing to accept above median risk of death were more likely to be male (17.1% vs 9.1%, P < 0.001), take higher levels of risks in their daily life (P = 0.008 for trend), and report continuous abdominal pain (53.1% vs 39.4%, P < 0.001), and had higher depression (P = 0.004 for trend) and lower quality of life (P < 0.001 for trend) scores. CONCLUSION: Patients are willing to accept significant risks in return for cure of their IBS symptoms.
引用
- Goodoory VC, Ng CE, Black CJ, et al. Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome. Aliment Pharmacol Ther. 2022. PMID: 35166374. doi:10.1111/apt.16816
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。